期刊文献+

液相色谱-质谱联用法同时测定生脉注射液中人参皂苷Rg_1、Re、Rb_1和五味子醇甲在健康人血浆的浓度 被引量:8

Determination the concentration of ginsenoside Rg_1,Re,Rb_1 and schisantherin A of shengmai injection in healthy human plasma by LC-MS/MS
下载PDF
导出
摘要 目的建立液相色谱-质谱联用法测定生脉注射液(心血管系统药)中人参皂苷Rg1、Re、Rb1和五味子醇甲在健康人血浆的浓度。方法血浆样品用乙腈沉淀法处理,用电喷雾离子化和正离子多离子反应监测方法,检测人参皂苷Rg1、Re、Rb1和五味子醇甲。结果 Rg1、Re、Rb1和五味子醇甲的线性范围分别为0.64~509.000,.62~501.00,1.180~4725.00,0.10~153.00μg.L-1;定量下线分别为0.64,0.62,1.18,0.10μg.L-1;方法回收率分别为78.55%~91.65%7,8.57%~104.98%,79.62%~93.17%,82.50%~104.80%;日内、日间RSD值均小于15%。结论该法准确、灵敏、特异,适用于血浆中生脉注射液中4种成分浓度的同时测定。 Objective To develop a LC-MS/MS method for the determination the concentration of ginsenoside Rg1,Re,Rb1 and schisantherin A of shengmai injection in healthy human plasma.Methods Plasma samples were pretreated by acetonitrile,ginsenoside Rg1,Re,Rb1 and schisantherin A was detected by the positive electrospray ionization method under multiple reaction monitoring mode.Results The calibration curve of ginsenoside Rg1,Re,Rb1 and schisantherin A in plasma was linear over the range of 0.64-509.00,0.62-501.00,1.18-4725.00 and 0.10-153.00 μg·L-1.The limit of quantitation was 0.64,0.62,1.18 and 0.10 μg·L-1.The relative were 78.55%-91.65%,78.57%-104.98%,79.62%-93.17% and 82.50%-104.80%,respectively.The within-day and between-day RSDs were less than 15%.Conclusion This method is accurate,sensitive,and specific,it is suitable for the measurement of plasma ginsenoside Rg1,Re,Rb1 and schisantherin A concentration.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2011年第10期789-792,共4页 The Chinese Journal of Clinical Pharmacology
基金 辽宁省教育厅基金资助项目(20060549)
关键词 人参皂苷Rg1 人参皂苷RE 人参皂苷RB1 五味子醇甲 LC-MS/MS联用仪 ginsenoside Rg1 ginsenoside Re ginsenoside Rb1 schisantherin A LC-MS/MS
  • 相关文献

参考文献3

二级参考文献14

  • 1陈勇敢,王荔,宋景芳.薄层扫描法测定冠心康颗粒中人参皂苷Re含量[J].中国药业,2004,13(9):30-31. 被引量:4
  • 2杨春梅,王玉蓉.HPLC测定眠而安滴丸中五味子醇甲的含量[J].中成药,2004,26(10):808-810. 被引量:12
  • 3刘华钢,赖茂祥,梁秋云,严克俭.三七含量测定方法的研究[J].中国实验方剂学杂志,2004,10(5):14-16. 被引量:21
  • 4YinLH WoXD.The advance in pharmacological and clinical studies of Shenmai injection .浙江中医学院学报,2001,25(6):65-68.
  • 5ChenZQ XuBY.Determination of ginsenoside Re in Shenmai injection by HPLC .中国中药杂志,1999,24(1):36-37.
  • 6LiZW XuXR.Bio—sample pretreatment method in chromatographic analysis [J].药物分析杂志,1996,16(1):55-59.
  • 7江苏新医学院编.中药大辞典(上册)[M].上海:上海科学技术出版社,1999.29-33.
  • 8中国药品生物制品检定所中国科学院植物研究室著.中药鉴别手册(第二册)[M].北京:科学出版社,1997:9-36.
  • 9娄之岑,徐珞珊.常用中药材品种整理和质量研究(北方协作组第2册)[M].北京:福建科学技术出版社,1994:299-162.
  • 10中国医学科学院药物研究所,等.中药志Ⅲ[M].北京:人民卫生出版社,1984:227-241.

共引文献36

同被引文献108

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部